AU767880B2 - Multigene vectors - Google Patents
Multigene vectors Download PDFInfo
- Publication number
- AU767880B2 AU767880B2 AU30943/99A AU3094399A AU767880B2 AU 767880 B2 AU767880 B2 AU 767880B2 AU 30943/99 A AU30943/99 A AU 30943/99A AU 3094399 A AU3094399 A AU 3094399A AU 767880 B2 AU767880 B2 AU 767880B2
- Authority
- AU
- Australia
- Prior art keywords
- gene
- cancer cell
- cell
- expression
- xxx
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7820598P | 1998-03-16 | 1998-03-16 | |
US60/078205 | 1998-03-16 | ||
PCT/US1999/005781 WO1999047690A2 (en) | 1998-03-16 | 1999-03-16 | Multigene vectors |
Publications (2)
Publication Number | Publication Date |
---|---|
AU3094399A AU3094399A (en) | 1999-10-11 |
AU767880B2 true AU767880B2 (en) | 2003-11-27 |
Family
ID=22142606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU30943/99A Ceased AU767880B2 (en) | 1998-03-16 | 1999-03-16 | Multigene vectors |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1064392A2 (de) |
JP (1) | JP2002506651A (de) |
AU (1) | AU767880B2 (de) |
CA (1) | CA2323112A1 (de) |
WO (1) | WO1999047690A2 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3642601A (en) * | 1999-11-05 | 2001-05-30 | Avigen, Inc. | Ecdysone-inducible adeno-associated virus expression vectors |
EP1266022B1 (de) * | 2000-03-24 | 2008-10-22 | Cell Genesys, Inc. | Interne ribosomenzugangsstelle-enthaltende zell-spezifische adenovirale vektoren |
GB2362884A (en) * | 2000-05-30 | 2001-12-05 | Isis Innovation | Extended duration of airway gene therapy |
US6579522B1 (en) | 2000-06-27 | 2003-06-17 | Genvec, Inc. | Replication deficient adenoviral TNF vector |
WO2002022176A1 (en) | 2000-09-15 | 2002-03-21 | Genvec, Inc. | Method of modulating neovascularization |
US6656732B1 (en) | 2001-05-18 | 2003-12-02 | Isis Pharmaceuticals, Inc. | Antisense inhibition of src-c expression |
EP1262199A1 (de) * | 2001-05-23 | 2002-12-04 | Fornix Biosciences N.V. | Vektoren zur gesteigerten Expression von VEGF zur Behandlung von Krankheiten |
EP1395292B1 (de) * | 2001-05-23 | 2007-11-21 | Fornix Biosciences N.V. | Vektoren zur gesteigerten expression von vegf zur behandlung von krankheiten |
US7223740B2 (en) | 2001-05-23 | 2007-05-29 | Fornix Biosciences N.V. | Vectors for enhanced expression of VEGF for atrial disease treatment |
US20030086903A1 (en) | 2001-11-02 | 2003-05-08 | Genvec, Inc. | Therapeutic regimen for treating cancer |
EP1501861A4 (de) | 2002-05-06 | 2007-06-20 | Univ Texas | Gezielt bindende proteine zur verabreichung therapeutischer oder diagnostischer reagentien |
CN1944655B (zh) * | 2006-09-04 | 2010-05-12 | 王尚武 | 靶向性共表达新型p53和p53AIP1的重组腺病毒 |
AU2014246731A1 (en) * | 2013-03-30 | 2015-11-19 | Usha Biotech Limited | Methods and constructs for expressing biologically active proteins in mammalian cells |
WO2015157636A1 (en) | 2014-04-10 | 2015-10-15 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy |
SG11201803940PA (en) * | 2015-10-23 | 2018-06-28 | Tetsuyuki Hirahata | Gene therapy composition |
EP3573637A4 (de) | 2017-01-27 | 2020-11-11 | Vanderbilt University | Nukleare fus-translokationsinhibitoren zur behandlung von fibrose |
CN108823208B (zh) * | 2018-06-29 | 2021-11-02 | 中国科学院过程工程研究所 | 一种四环素诱导启动子及其制备方法和应用 |
WO2022081776A1 (en) | 2020-10-13 | 2022-04-21 | Kriya Therapeutics, Inc. | Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
IL107250A (en) * | 1993-10-12 | 2001-08-08 | Yeda Res & Dev | Dna molecules involved in programmed cell death, proteins encoded thereby and methods and compositions using said dna molecules and proteins |
FR2722208B1 (fr) * | 1994-07-05 | 1996-10-04 | Inst Nat Sante Rech Med | Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique |
DE19514310A1 (de) * | 1995-04-18 | 1996-10-24 | Univ Ludwigs Albert | Vektoren zur Transfektion von eukaryotischen Zellen, deren Verwendung und damit transfizierte Zielzellen |
FR2755975B1 (fr) * | 1996-11-15 | 1999-05-07 | Rhone Poulenc Rorer Sa | Virus recombinants bicistroniques utiles pour le traitement de pathologies liees aux dyslipoproteinemies |
-
1999
- 1999-03-16 CA CA002323112A patent/CA2323112A1/en not_active Abandoned
- 1999-03-16 WO PCT/US1999/005781 patent/WO1999047690A2/en not_active Application Discontinuation
- 1999-03-16 EP EP99912601A patent/EP1064392A2/de not_active Withdrawn
- 1999-03-16 AU AU30943/99A patent/AU767880B2/en not_active Ceased
- 1999-03-16 JP JP2000536873A patent/JP2002506651A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1999047690A2 (en) | 1999-09-23 |
JP2002506651A (ja) | 2002-03-05 |
WO1999047690A3 (en) | 1999-11-18 |
AU3094399A (en) | 1999-10-11 |
CA2323112A1 (en) | 1999-09-23 |
EP1064392A2 (de) | 2001-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU767880B2 (en) | Multigene vectors | |
US6630344B1 (en) | Diminishing viral gene expression by promoter replacement | |
ES2338288T3 (es) | Metodo mejorado para la produccion y purificacion de vectores adenovirales. | |
US6899870B1 (en) | Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery | |
US7033750B2 (en) | Recombinant P53 adenovirus methods and compositions | |
CN1244215B (zh) | 改进的腺病毒载体生产和纯化方法 | |
US6855549B1 (en) | Methods and compositions for increasing the infectivity of gene transfer vectors | |
JP2000501394A (ja) | ガンの診断および処置のための方法および組成物 | |
US6251871B1 (en) | P16 expression constructs and their application in cancer therapy | |
AU762493B2 (en) | Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery | |
US20060193832A1 (en) | Use of the sodium iodine symporter to effect uptake of iodine | |
JP2005500247A (ja) | ヒトmda−7に関わる処置方法 | |
US6517828B1 (en) | C-CAM as an angiogenesis inhibitor | |
JP2006519614A (ja) | 悪性かつ形質転換した哺乳動物細胞を選択的に殺すペプチド | |
KR19980068555A (ko) | 암 억제 단백질인 p53 을 생산하는 아데노바이러스 및 이를 항암 치료에 사용하는 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |